Gufic Biosciences: Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30,…
Gufic Biosciences (GUFICBIO) filed a disclosure titled "Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith". The company is valued at about ₹4,884 crore.
What happened
Gufic Biosciences (GUFICBIO) filed a disclosure with the exchanges on 14 November 2026 at 08:22 PM titled "Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith".
Company snapshot
Gufic Biosciences is a small-cap company, with a market value of about ₹4,884 crore.
The stock last traded at ₹487, against a 52-week range of ₹268–₹494 (1.4% below the high).
Before this filing the shares had moved +18.1% over the month and +14.6% over three months. Average daily turnover over the last 20 sessions was about ₹6.28 crore.
Promoters held 72.50% at the end of Q1 FY27. Foreign institutions owned 0.46% and domestic institutions 3.68%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 224 | 13.1 | 1.3 |
| Q2 FY26 | 237 | 16.8 | 1.68 |
| Q3 FY26 | 231 | 12.4 | 1.24 |
| Q4 FY26 | 252 | 21.9 | 2.18 |
| Q1 FY27 | 261 | 22.3 | 2.22 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock gained 2.2% on average the next trading day and was up 5.9% on average after five days (2 filings with price data).
Market-wide, 11,811 results filings with an impact score of 50 or more saw an average next-day move of −0.2%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 14 Aug 2026 | , the financial results for the period ended Jun 30, 2026. and… | −0.2% | −1.0% |
| 29 May 2026 | Results - Audited Financial Results (Standalone And Consolidated)… | +4.6% | +12.8% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 14 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.